| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of voriconazole against Candida albicans and Candida krusei isolated since 1984
|
Lee, Jenny K.
|
|
2000
|
16 |
3 |
p. 205-209
5 p.
|
artikel
|
| 2 |
Anaerobic infection therapy
|
Giamarellou, Helen
|
|
2000
|
16 |
3 |
p. 341-346
6 p.
|
artikel
|
| 3 |
Analysis of drug costs in a domiciliary care unit for AIDS patients: a 3-year survey
|
Beltrame, A
|
|
2000
|
16 |
3 |
p. 363-364
2 p.
|
artikel
|
| 4 |
Antibiotic usage and resistance — trends in Estonian University Hospitals
|
Naaber, Paul
|
|
2000
|
16 |
3 |
p. 309-315
7 p.
|
artikel
|
| 5 |
A 10 year study of resistance of Staphylococcus aureus to selected antimicrobials in three Venezuelan centres
|
Rodrı́guez, Alfonso J.
|
|
2000
|
16 |
3 |
p. 253-
1 p.
|
artikel
|
| 6 |
Cellular factors involved in the induction of resistance of HIV to antiretroviral agents
|
Turriziani, O
|
|
2000
|
16 |
3 |
p. 353-356
4 p.
|
artikel
|
| 7 |
Ciprofloxacin versus chloramphenicol in the treatment of salmonella infection
|
Liberti, Alfonso
|
|
2000
|
16 |
3 |
p. 347-348
2 p.
|
artikel
|
| 8 |
Compliance to combination antiretroviral therapy in HIV-1 infected children
|
Boni, Silvia
|
|
2000
|
16 |
3 |
p. 371-372
2 p.
|
artikel
|
| 9 |
Current and future antifungal therapy: new targets for antifungal therapy
|
Andriole, Vincent T
|
|
2000
|
16 |
3 |
p. 317-321
5 p.
|
artikel
|
| 10 |
Decrease of antibiotic resistance in Salmonella typhi isolated from patients attending hospitals of Dhaka City over a 3 year period
|
Zahurul Haque Asna, S.M.
|
|
2000
|
16 |
3 |
p. 249-251
3 p.
|
artikel
|
| 11 |
Development and persistence of multi-resistance to antibiotics in bacteria; an analysis and a new approach to this urgent problem
|
van der Waaij, Dirk
|
|
2000
|
16 |
3 |
p. 191-197
7 p.
|
artikel
|
| 12 |
Does HGV–HIV co-infection exist?
|
Pontali, Emanuele
|
|
2000
|
16 |
3 |
p. 349-351
3 p.
|
artikel
|
| 13 |
Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects
|
de Gaetano Donati, K
|
|
2000
|
16 |
3 |
p. 357-360
4 p.
|
artikel
|
| 14 |
Emerging and reemerging pathogens
|
Gomez-Lus, R
|
|
2000
|
16 |
3 |
p. 335-339
5 p.
|
artikel
|
| 15 |
Epidemiological survey of bacterial resistance in upper respiratory tract infections in Italy
|
Cornaglia, G
|
|
2000
|
16 |
3 |
p. 259-262
4 p.
|
artikel
|
| 16 |
Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period
|
Ferrero, M.
|
|
2000
|
16 |
3 |
p. 245-248
4 p.
|
artikel
|
| 17 |
First report of ampicillin and glycopeptide resistant Enterococcus faecium VanA bacteraemia in Greece
|
Kouppari, G.
|
|
2000
|
16 |
3 |
p. 254-256
3 p.
|
artikel
|
| 18 |
Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy
|
Bassetti, M.
|
|
2000
|
16 |
3 |
p. 295-299
5 p.
|
artikel
|
| 19 |
In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria
|
Schaumann, Reiner
|
|
2000
|
16 |
3 |
p. 225-232
8 p.
|
artikel
|
| 20 |
In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections
|
Naber, Kurt G
|
|
2000
|
16 |
3 |
p. 239-243
5 p.
|
artikel
|
| 21 |
Licensing new antibacterial agents — a European perspective
|
Powell, Mair
|
|
2000
|
16 |
3 |
p. 199-203
5 p.
|
artikel
|
| 22 |
Making the diagnosis of fungal infection: when to start treatment
|
Martino, Pietro
|
|
2000
|
16 |
3 |
p. 323-329
7 p.
|
artikel
|
| 23 |
Mechanisms and clinical significance of antifungal resistance
|
Bille, J.
|
|
2000
|
16 |
3 |
p. 331-333
3 p.
|
artikel
|
| 24 |
Mediterranean clone of penicillin-susceptible, multidrug-resistant serotype 6B Streptococcus pneumoniae in Greece, Italy and Israel
|
Syrogiannopoulos, George A
|
|
2000
|
16 |
3 |
p. 219-224
6 p.
|
artikel
|
| 25 |
Natural antibiotic susceptibility of Salmonella enterica strains
|
Stock, I
|
|
2000
|
16 |
3 |
p. 211-217
7 p.
|
artikel
|
| 26 |
New antibiotics for community-acquired lower respiratory tract infections: improved activity at a cost?
|
Ball, Peter
|
|
2000
|
16 |
3 |
p. 263-272
10 p.
|
artikel
|
| 27 |
Nutritional status changes in HIV-infected children receiving combined antiretroviral therapy including protease inhibitors
|
Fiore, Paolo
|
|
2000
|
16 |
3 |
p. 365-369
5 p.
|
artikel
|
| 28 |
Outer membrane changes in Pseudomonas stutzeri resistant to chlorhexidine diacetate and cetylpyridinium chloride
|
Tattawasart, Unchalee
|
|
2000
|
16 |
3 |
p. 233-238
6 p.
|
artikel
|
| 29 |
Pharmacokinetic/pharmacodynamic predictors of time to clinical resolution in patients with acute bacterial exacerbations of chronic bronchitis treated with a fluoroquinolone
|
Meinl, Barbara
|
|
2000
|
16 |
3 |
p. 273-280
8 p.
|
artikel
|
| 30 |
Response-adjusted α-interferon therapy for chronic hepatitis C in HIV-infected patients
|
Prestileo, Tullio
|
|
2000
|
16 |
3 |
p. 373-378
6 p.
|
artikel
|
| 31 |
Sequential or switch treatment — which criteria should be fulfilled?
|
Shah, Pramod M
|
|
2000
|
16 |
3 |
p. 301-302
2 p.
|
artikel
|
| 32 |
The role of antimicrobial policies in neutropenic patients
|
Martino, Pietro
|
|
2000
|
16 |
3 |
p. 303-307
5 p.
|
artikel
|
| 33 |
The role of fluoroquinolones in respiratory tract infections: community acquired pneumonia
|
Garcı́a-Rodrı́guez, J.A.
|
|
2000
|
16 |
3 |
p. 281-285
5 p.
|
artikel
|
| 34 |
The role of the hospital pharmacist in cost control and antibiotic policy
|
Milkovich, Gary
|
|
2000
|
16 |
3 |
p. 291-294
4 p.
|
artikel
|
| 35 |
Tolerance of highly active antiretroviral therapy in HIV patients: a 3-year follow up
|
Beltrame, A.
|
|
2000
|
16 |
3 |
p. 361-362
2 p.
|
artikel
|
| 36 |
What's new in streptococcal pharyngitis
|
Boccazzi, Antonio
|
|
2000
|
16 |
3 |
p. 287-289
3 p.
|
artikel
|
Tijdschrift beschrijving